Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results

Main Article Content

Nuria Albareda
Noah Rosenberg
Sandra Roth
Ilonka Zsolt
Theodore Rosen
Adelaide A Hebert


impetigo, ozenoxacin, antimicrobial, clinical trial


Abstract Not Available

Most read articles by the same author(s)

1 2 > >>